BeStock  

Bioventus BVS

US equityMarket cap rank #3408Medical Devices
$9.88 −$0.07 (-0.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.88 0.00%
Open$9.85
Prev close$9.95
Day range$9.81 – $10.17
Volume612.4K
Market cap$676.53M
P/E (TTM)12.2
Dividend yield–

BVS Stock News

Headlines matching Bioventus or the BVS ticker, most recent first.

  • CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15Market news · 6 Aug 2026 · Direct mention
  • Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 6 Aug 2026 · Direct mention
  • Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 6 Aug 2026 · Direct mention
  • Earnings Flash (BVS) Bioventus Inc. Posts Q2 Adjusted EPS $0.22 per Share, Vs. FactSet Est of $0.22MT Newswires · 5 Aug 2026 · Direct mention
  • J.P. Morgan Keeps Their Hold Rating on Bravura Solutions Limited (BVS)TipRanks · 17 Aug 2026 · Direct mention
  • CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $19Market news · 17 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crinetics Pharmaceuticals (CRNX)TipRanks · 7 Jul 2026 · Direct mention
  • Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16Market news · 7 Jul 2026 · Direct mention
  • Barrington Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $14Market news · 6 Jul 2026 · Direct mention
  • Craig-Hallum Maintains Bioventus(BVS.US) With Buy RatingMarket news · 24 May 2026 · Direct mention
  • Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $14 PositiveMarket news · 6 Mar 2026 · Direct mention
  • CJS Securities Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $14Market news · 27 Mar 2026 · Direct mention
  • Barrington Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $13Market news · 9 Feb 2026 · Direct mention
  • Barrington Maintains Bioventus(BVS.US) With Buy Rating, Cuts Target Price to $16 NegativeMarket news · 3 Nov 2026 · Direct mention
  • CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $18Market news · 3 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BVS.

Sign in to join the discussion.

Scroll to Top